Irvine, Calif. – July 18, 2012 – C. K. Cooper &
Company, an independent, full-service investment bank, headquartered in
Irvine, Calif., announced today that Suraj Kalia has joined the firm as a
Managing Director in the Healthcare Research Department.
Over the past 9 years, Mr. Kalia has focused primarily
on Medical Device issuers having developed a reputation as a thought
leader in the identification of emerging technologies. Previously at
Rodman and Renshaw, Mr. Kalia covered 22 issuers ranging in market
capitalizations from $20 million to $10 billion. Prior to joining Rodman
and Renshaw in 2007, Mr, Kalia provided research at Sanders Morris
Harris, Piper Jaffray & Co. and Northland Securities.
Commenting on the addition to the Healthcare Team at
C. K. Cooper & Company, Bilal Basrai Director in the Corporate
Finance Group – Healthcare commented, “Suraj’s broad range of experience
and prior coverage of healthcare names fits well with our core
investment thesis. We expect him to bring immediate value to our
clients through his insightful research. We are pleased and excited to
have Suraj as part of the team.”
Mr. Kalia added, “I look forward to being part of the team tasked with building out the healthcare franchise at C. K. Cooper”.
Mr. Kalia is a Chartered Financial Analyst. He has a
Bachelor of Technology degree from Indian Institute of Technology, a
Masters of Engineering from Stevens Institute of Technology and a MBA
from the University of St. Thomas, in Minneapolis Minnesota.
About C. K. Cooper & Company
C. K. Cooper & Company is a full-service
investment bank headquartered in Irvine, California. The Company is
focused on providing superior and insightful research coverage to its
clients; innovative investment banking solutions supported by sales and
trading services; and portfolio advisory and management services for
private clients. Though C. K. Cooper & Company has been noted for a
variety of measures of accomplishment, we chart our success by only one
metric: The growth of our clients. For more about C. K. Cooper &
Company, visit www.ckcooper.com.
For more information, please contact: C. K. Cooper
& Company – 18300 Von Karman Ave., Suite 700, Irvine CA 92612 –
(949) 477-9300 – administration@ckcooper.com
The information contained herein is not a complete
analysis of every material fact respecting any company, industry or
security. Although opinions and estimates expressed herein reflect the
current judgment of C. K. Cooper & Company, the information upon
which such opinions and estimates are based is not necessarily updated
on a regular basis; when it is, the date of the change in estimate will
be noted. In addition, opinions and estimates are subject to change
without notice. This report contains forward-looking statements, which
involve risks and uncertainties. Actual results may differ significantly
from the results described in the forward-looking statements. Factors
that might cause such a difference include, but are not limited to,
those discussed in "Investment Risks." C. K. Cooper & Company from
time to time perform corporate finance or other services for some
companies described herein and may occasionally possess material,
nonpublic information regarding such companies. This information is not
used in the preparation of the opinions and estimates herein. While the
information contained in this Report and the opinions contained herein
are based on sources believed to be reliable, C. K. Cooper & Company
has not independently verified the facts, assumptions and estimates
contained in this Report. Accordingly, no representation or warranty,
expressed or implied, is made as to, and no reliance should be placed
on, the fairness, accuracy, completeness or correctness of the
information and opinions contained in this Report. C. K. Cooper &
Company, its managing directors, its affiliates, and/or its employees
may have an interest in the securities of the issue(s) described and may
make purchases or sales while this report is in circulation.
administration@ckcooper.com
www.ckcooper.com
